EGFR TKI resistance via role VEGFR2

被引：0
|
作者：
Osude, Chike [1 ]
Lin, Leo [1 ]
Puri, Neelu [1 ]
机构：
[1] Univ Illinois, Coll Med, Rockford, IL 61107 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-189
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
189
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Management of patients with resistance to EGFR-TKI
    Barlesi, F.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2011, 67 : S30 - S35
  • [42] CHRONIC NICOTINE EXPOSURE MEDIATES RESISTANCE TO EGFR-TKI IN EGFR-MUTATED LUNG CANCER VIA EGFR SIGNAL
    Hayashi, Hidetoshi
    Togashi, Yosuke
    Okamoto, Kunio
    Fumita, Soichi
    Terashima, Masato
    Sakai, Kazuko
    Fujita, Yoshihiko
    Tomida, Shuta
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    ANNALS OF ONCOLOGY, 2014, 25
  • [43] Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung Cancer
    Osude, Chike
    Lin, Leo
    Patel, Meet
    Eckburg, Adam
    Berei, Joseph
    Kuckovic, Adijan
    Dube, Namrata
    Rastogi, Aayush
    Gautam, Shruti
    Smith, Thomas J.
    Sreenivassappa, Shylendra B.
    Puri, Neelu
    CELLS, 2022, 11 (10)
  • [44] Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal
    Togashi, Yosuke
    Hayashi, Hidetoshi
    Okamoto, Kunio
    Fumita, Soichi
    Terashima, Masato
    de Velasco, Marco A.
    Sakai, Kazuko
    Fujita, Yoshihiko
    Tomida, Shuta
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    LUNG CANCER, 2015, 88 (01) : 16 - 23
  • [45] Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives
    Alkamaly, Omkulthom M.
    Altwaijry, Najla
    Sabour, Rehab
    Harras, Marwa F.
    ARCHIV DER PHARMAZIE, 2021, 354 (04)
  • [46] Prioritization of EGFR/IGF-IR/VEGFR2 Combination Targeted Therapies Utilizing Cancer Models
    Tonra, James R.
    Corcoran, Erik
    Deevi, Dhanvanthri S.
    Steiner, Philipp
    Kearney, Jessica
    Li, Huiling
    Ludwig, Dale L.
    Zhu, Zhenping
    Witte, Larry
    Surguladze, David
    Hicklin, Daniel J.
    ANTICANCER RESEARCH, 2009, 29 (06) : 1999 - 2007
  • [47] MMPP is a novel VEGFR2 inhibitor that suppresses angiogenesis via VEGFR2/AKT/ERK/NF-1cB 1c B pathway
    Kim, Na-Yeon
    Park, Hyo-Min
    Park, Jae-Young
    Kim, Uijin
    Shin, Ha Youn
    Lee, Hee Pom
    Hong, Jin Tae
    Yoon, Do-Young
    BMB REPORTS, 2024, 57 (05) : 244 - 249
  • [48] Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway
    Xie, Qian
    Wang, Jing
    Wu, Wenwen
    Zhao, Ye
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (01): : 421 - 431
  • [49] Mechanotransduction via endothelial adhesion molecule CD31 initiates transmigration and reveals a role for VEGFR2 in diapedesis
    Fu, Tao
    Sullivan, David P.
    Gonzalez, Annette M.
    Haynes, Maureen E.
    Dalal, Prarthana J.
    Rutledge, Nakisha S.
    Tierney, Abigail L.
    Yescas, Julia A.
    Weber, Evan W.
    Muller, William A.
    IMMUNITY, 2023, 56 (10) : 2311 - +
  • [50] Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer
    Ma, Shiqi
    Zhang, Lu
    Ren, Yuan
    Dai, Wei
    Chen, Tingqing
    Luo, Liping
    Zeng, Juan
    Mi, Kun
    Lang, Jinyi
    Cao, Bangrong
    ONCOGENE, 2021, 40 (14) : 2596 - 2609
12345